8-K: Assure Holdings Corp. to Merge with Danam Health, Inc. in All-Stock Transaction

Assure Holdings Corp. and Danam Health, Inc. have agreed to merge in an all-stock transaction, creating a combined company focused on pharmaceutical and healthcare services.

Summary

• Assure Holdings Corp. will merge with Danam Health, Inc., with Danam becoming a wholly-owned subsidiary of Assure.
• The merger is structured as a stock-for-stock exchange, where Danam's equity will be exchanged for Assure common stock.
• Post-merger, current Danam stockholders are expected to own approximately 90% of the combined company, while current Assure stockholders will own about 10%.
• The combined company is valued at approximately $150 million on a fully diluted basis.
• Assure will be renamed Danam Health Holdings Corp. and will continue to be listed on the Nasdaq.
• The merger is expected to close in the second quarter of 2024, pending certain closing conditions.
• Suren Ajjarapu will serve as Chairman of the combined company, and the board will consist of five members designated by Danam.

Sentiment

Score: 6

Explanation: The document presents a significant strategic shift for Assure, with a merger that heavily favors Danam's shareholders. While the language is positive about the combined entity's potential, the dilution for existing Assure shareholders and the risks involved temper the overall sentiment.

Positives

• The merger creates a combined company focused on pharmaceutical and healthcare services.
• Danam's micro health ecosystem is expected to be advanced through the merger.
• The combined company is anticipated to include a portfolio of companies with pharmacy, wholesale operations, and a technology division.
• Danam's patient-centric approach and innovative healthcare applications are expected to improve patient care.
• The merger is expected to provide a vehicle for future expansion.

Negatives

• Current Assure stockholders will have a significantly reduced ownership stake in the combined company (approximately 10%).
• The merger is subject to several closing conditions, including shareholder approvals and a sale of assets by Assure, which could delay or prevent the transaction.

Risks

• The merger is subject to closing conditions, including shareholder approvals and a sale of assets by Assure, which may not be satisfied.
• There are uncertainties regarding the timing of the consummation of the merger.
• Assure faces risks related to managing operating expenses and transaction-related expenses pending closing.
• There are risks related to obtaining required approvals from governmental entities.
• The exchange ratio may be adjusted, potentially altering the ownership percentages of Assure and Danam stockholders.
• The market price of Assure's common stock is subject to risks.
• Unexpected costs, charges, or expenses may result from the proposed transaction.
• Potential adverse reactions or changes to business relationships may occur due to the announcement or completion of the merger.
• The combined company may face challenges in obtaining sufficient additional capital to advance its business plan.
• There are risks associated with the possible failure to realize certain anticipated benefits of the proposed transactions.

Future Outlook

The combined company will focus on pharmaceutical and healthcare services, advancing Danam's micro health ecosystem and is anticipated to include a portfolio of companies with pharmacy, wholesale operations and a technology division with a novel platform for hub and clinical services.

Management Comments

• Suren Ajjarapu, Chairman of Danam Health, stated, 'We are very excited about the merger and believe the new combined company will provide the vehicle for our future expansion.'
• Suren Ajjarapu also mentioned, 'Our mission at Danam is to empower our network of pharmacy partners and patients by providing cost savings on pharmaceutical products, automating patient centric services and overcoming inefficiencies that prevent optimal patient care.'

Industry Context

This merger reflects a trend of consolidation in the healthcare and pharmaceutical sectors, where companies are seeking to expand their service offerings and market reach through strategic combinations. The focus on technology and patient-centric solutions aligns with the industry's move towards more integrated and efficient healthcare delivery models.

Comparison to Industry Standards

• The all-stock merger structure is a common approach in the healthcare industry, particularly for companies seeking to combine resources and expertise.
• The valuation of $150 million for the combined entity is within the range of similar transactions involving companies in the pharmaceutical and healthcare services space, although specific comparables would require a deeper analysis of the companies' financials and market positions.
• The expected ownership split of 90% for Danam stockholders and 10% for Assure stockholders reflects the relative valuations and contributions of each company to the combined entity.
• The focus on technology and patient-centric solutions aligns with industry trends towards digital health and personalized medicine, as seen in companies like Teladoc Health and GoodRx.

Management Changes

Stakeholder Impact

• Assure stockholders will experience significant dilution in their ownership stake.
• Danam stockholders will become the majority owners of the combined company.
• Employees of both companies may experience changes in their roles and responsibilities.
• Customers of both companies may see changes in the services and products offered.
• Suppliers of both companies may be affected by the merger.

Next Steps

• Assure and Danam will file a registration statement on Form S-4 with the SEC.
• The companies will seek shareholder approval for the merger.
• The combined company will apply for continued listing on the Nasdaq.
• The merger is expected to close in the second quarter of 2024.

Key Dates

Keywords

merger, acquisition, pharmaceutical, healthcare, stock transaction, Danam Health, Assure Holdings, Nasdaq, business combination, healthcare services